{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:34:17Z","timestamp":1793424857982,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00417-025-07058-3","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:05:51Z","timestamp":1770278751000},"page":"2105-2118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["How do genetic polymorphisms influence the efficacy of age-related macular degeneration treatments? A systematic review and meta-analysis"],"prefix":"10.1007","volume":"264","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"5-a Suppl","key":"7058_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.18553\/jmcp.2023.29.5-a.s2","volume":"29","author":"SJ Bakri","year":"2023","unstructured":"Bakri SJ, Bektas M, Sharp D, Luo R, Sarda SP, Khan S (2023) Geographic atrophy: mechanism of disease, pathophysiology, and role of the complement system. J Manag Care Spec Pharm 29(5-a Suppl):S2-s11. https:\/\/doi.org\/10.18553\/jmcp.2023.29.5-a.s2","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"7058_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ophtha.2020.02.027","volume":"127","author":"S Kiss","year":"2020","unstructured":"Kiss S et al (2020) Management and outcomes for neovascular age-related macular degeneration: analysis of United States electronic health records. Ophthalmology 127(9):1179\u20131188. https:\/\/doi.org\/10.1016\/j.ophtha.2020.02.027","journal-title":"Ophthalmology"},{"issue":"4","key":"7058_CR3","doi-asserted-by":"publisher","first-page":"E696","DOI":"10.1073\/pnas.1718059115","volume":"115","author":"DG Vavvas","year":"2018","unstructured":"Vavvas DG, Small KW, Awh CC, Zanke BW, Tibshirani RJ, Kustra R (2018) CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation,. Proc Natl Acad Sci U S A 115(4):E696\u2013E704. https:\/\/doi.org\/10.1073\/pnas.1718059115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7058_CR4","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1111\/j.1755-3768.2010.02080.x","volume":"89","author":"C Nischler","year":"2011","unstructured":"Nischler C et al (2011) Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration,. Acta Ophthalmol 89(4):e344-9. https:\/\/doi.org\/10.1111\/j.1755-3768.2010.02080.x","journal-title":"Acta Ophthalmol"},{"key":"7058_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jmgm.2017.12.023","volume":"80","author":"F Jahanfar","year":"2018","unstructured":"Jahanfar F, Hamishehkar H (2018) Exploring the association of rs10490924 polymorphism with age-related macular degeneration: an in silico approach,. J Mol Graph Model 80:52\u201358. https:\/\/doi.org\/10.1016\/j.jmgm.2017.12.023","journal-title":"J Mol Graph Model"},{"issue":"4","key":"7058_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/aos.13049","volume":"94","author":"N Hong","year":"2016","unstructured":"Hong N, Shen Y, Yu CY, Wang SQ, Tong JP (2016) Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis,. Acta Ophthalmol 94(4):334\u201345. https:\/\/doi.org\/10.1111\/aos.13049","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"7058_CR7","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1111\/aos.13494","volume":"96","author":"MH Jabbarpoor Bonyadi","year":"2018","unstructured":"Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Soheilian M (2018) Association of risk genotypes of ARMS2\/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis,. Acta Ophthalmol 96(2):e105\u2013e110. https:\/\/doi.org\/10.1111\/aos.13494","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"7058_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000508738","volume":"64","author":"J Zhang","year":"2021","unstructured":"Zhang J, Liu Z, Hu S, Qi J (2021) Meta-analysis of the pharmacogenetics of ARMS2 A69S polymorphism and the response to advanced age-related macular degeneration. Ophthalmic Res 64(2):192\u2013204. https:\/\/doi.org\/10.1159\/000508738","journal-title":"Ophthalmic Res"},{"key":"7058_CR9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"2","key":"7058_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5195\/jmla.2022.1449","volume":"110","author":"ML Rethlefsen","year":"2022","unstructured":"Rethlefsen ML, Page MJ (2022) PRISMA 2020 and PRISMA-S: common questions on tracking records and the flow diagram,. J Med Libr Assoc 110(2):253\u2013257. https:\/\/doi.org\/10.5195\/jmla.2022.1449","journal-title":"J Med Libr Assoc"},{"key":"7058_CR11","first-page":"603","volume":"25","author":"G Wells","year":"2011","unstructured":"Wells G, Shea B, O\u2019Connell DJ, Peterson WV (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"7058_CR12","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials,. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"7058_CR13","doi-asserted-by":"publisher","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis, (in eng). Stat Med\u00a021(11):1539-58. https:\/\/doi.org\/10.1002\/sim.1186","DOI":"10.1002\/sim.1186"},{"key":"7058_CR14","doi-asserted-by":"publisher","unstructured":"Almeida LN et al (2013) Association analysis of CFH and ARMS2 gene polymorphisms in a Brazilian cohort with age-related macular degeneration, (in eng). Ophthalmic Res 50(2): 117\u2009-22. https:\/\/doi.org\/10.1159\/000350549","DOI":"10.1159\/000350549"},{"issue":"03","key":"7058_CR15","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.21746\/ijbio.2015.03.0015","volume":"4","author":"D Gupta","year":"2015","unstructured":"Gupta D, Gupta V, Singh V, Chawla S, Prajnya R, Phadke SR (2015) Study of polymorphisms in CFH, ARMS2 and HTRA1 genes as potential risk factors for age related macular degeneration in Indian patients. Int J Bioassays 4(03):3747\u20133752. https:\/\/doi.org\/10.21746\/ijbio.2015.03.0015","journal-title":"Int J Bioassays"},{"issue":"4","key":"7058_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10792-019-01274-7","volume":"40","author":"K Gourgouli","year":"2020","unstructured":"Gourgouli K et al (2020) Investigation of genetic base in the treatment of age-related macular degeneration. Int Ophthalmol 40(4):985\u2013997. https:\/\/doi.org\/10.1007\/s10792-019-01274-7","journal-title":"Int Ophthalmol"},{"key":"7058_CR17","doi-asserted-by":"publisher","unstructured":"Cruz-Gonz\u00e1lez F, Est\u00e9vez LC, Campos CC, S\u00e1nchez AS-J, Marcos LJ, Gonz\u00e1lez-Sarmiento R (2016) The presence of CFH, HTRA1, ARMS2, VEGF-A and VEGF-R and the appearance of age-related macular degeneration sub-types.\u00a0Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition) 91(4):177\u2013183. https:\/\/doi.org\/10.1016\/j.oftale.2015.12.015","DOI":"10.1016\/j.oftale.2015.12.015"},{"issue":"3","key":"7058_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jamaophthalmol.2013.713","volume":"131","author":"R Klein","year":"2013","unstructured":"Klein R et al (2013) Risk alleles in CFH and ARMS2 and the Long-term natural history of Age-Related macular degeneration: the beaver dam eye study. JAMA Ophthalmol 131(3):383\u2013392. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.713","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"7058_CR19","doi-asserted-by":"publisher","first-page":"e0119570","DOI":"10.1371\/journal.pone.0119570","volume":"10","author":"CW Wong","year":"2015","unstructured":"Wong CW et al (2015) Lens status influences the association between CFH polymorphisms and Age-Related macular degeneration: findings from two Population-Based studies in Singapore. PLoS One 10(3):e0119570-e. https:\/\/doi.org\/10.1371\/journal.pone.0119570","journal-title":"PLoS One"},{"key":"7058_CR20","doi-asserted-by":"publisher","unstructured":"Dzenita S et al (2012) Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration.\u00a0Ophthalmology 119(11):2304\u20132311. https:\/\/doi.org\/10.1016\/j.ophtha.2012.05.040","DOI":"10.1016\/j.ophtha.2012.05.040"},{"key":"7058_CR21","doi-asserted-by":"publisher","unstructured":"Mello E, Falsini B, Zuppi C, Giardina B, Concolino P, Capoluongo E (2012) Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-related macular degeneration using high-resolution melting analysis. Clin Chem Lab Med 50(6). https:\/\/doi.org\/10.1515\/cclm-2011-0859","DOI":"10.1515\/cclm-2011-0859"},{"issue":"3","key":"7058_CR22","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1167\/iovs.13-13420","volume":"55","author":"L Ersoy","year":"2014","unstructured":"Ersoy L et al (2014) Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older. Invest Ophthalmol Vis Sci 55(3):1842\u20131847. https:\/\/doi.org\/10.1167\/iovs.13-13420","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"7058_CR23","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1167\/iovs.10-5554","volume":"51","author":"H Hayashi","year":"2010","unstructured":"Hayashi H et al (2010) CFHandARMS2Variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 51(11):5914. https:\/\/doi.org\/10.1167\/iovs.10-5554","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7058_CR24","doi-asserted-by":"publisher","unstructured":"Thakkinstian A et al (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration, (in eng). Hum Mol Genet\u00a015(18):2784-90.\u00a0https:\/\/doi.org\/10.1093\/hmg\/ddl220","DOI":"10.1093\/hmg\/ddl220"},{"issue":"8","key":"7058_CR25","doi-asserted-by":"publisher","first-page":"e42464","DOI":"10.1371\/journal.pone.0042464","volume":"7","author":"H Chen","year":"2012","unstructured":"Chen H, Yu K-D, Xu G-Z (2012) Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis. PLoS One 7(8):e42464. https:\/\/doi.org\/10.1371\/journal.pone.0042464","journal-title":"PLoS One"},{"issue":"2","key":"7058_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG et al (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48(2):134\u2013143. https:\/\/doi.org\/10.1038\/ng.3448","journal-title":"Nat Genet"},{"issue":"4","key":"7058_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mam.2012.04.004","volume":"33","author":"MB Gorin","year":"2012","unstructured":"Gorin MB (2012) Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med 33(4):467\u2013486. https:\/\/doi.org\/10.1016\/j.mam.2012.04.004","journal-title":"Mol Aspects Med"},{"key":"7058_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","volume":"40","author":"L Sobrin","year":"2014","unstructured":"Sobrin L, Seddon JM (2014) Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res 40:1\u201315. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.12.004","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"7058_CR29","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1167\/iovs.10-7070","volume":"52","author":"Y Yu","year":"2011","unstructured":"Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM (2011) Association of variants in theLIPCandABCA1Genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 52(7):4663. https:\/\/doi.org\/10.1167\/iovs.10-7070","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7058_CR30","doi-asserted-by":"publisher","unstructured":"Priya RR, Chew EY, Swaroop A (2012) Genetic Studies of age-related macular degeneration.\u00a0Ophthalmology\u00a0119(12):2526\u20132536. https:\/\/doi.org\/10.1016\/j.ophtha.2012.06.042","DOI":"10.1016\/j.ophtha.2012.06.042"},{"key":"7058_CR31","doi-asserted-by":"publisher","unstructured":"Lambert NG et al (2016) Risk factors and biomarkers of age-related macular degeneration, (in eng). Prog Retin Eye Res 54:64\u2013102. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.003","DOI":"10.1016\/j.preteyeres.2016.04.003"},{"key":"7058_CR32","doi-asserted-by":"publisher","unstructured":"Chew EY et al (2013) Long-Term Effects of Vitamins C and E, \u03b2-Carotene, and Zinc on Age-related Macular Degeneration. Ophthalmology 120(8):1604\u20131611.e4. https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.021","DOI":"10.1016\/j.ophtha.2013.01.021"},{"issue":"12","key":"7058_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111344","volume":"27","author":"CC Xue","year":"2024","unstructured":"Xue CC et al (2024) Lipid-lowering drug and complement factor H genotyping-personalized treatment strategy for age-related macular degeneration. iScience 27(12):111344. https:\/\/doi.org\/10.1016\/j.isci.2024.111344","journal-title":"iScience"},{"key":"7058_CR34","doi-asserted-by":"crossref","unstructured":"Chan CM, Huang DY, Sekar P, Hsu SH, Lin WW. Reactive oxygen species-dependent mitochondrial dynamics and autophagy confer protective effects in retinal pigment epithelial cells against sodium iodate-induced cell death. J Biomed Sci. 2019;26(1):40. Published 2019 May 22. doi:10.1186\/s12929-019-0531-z","DOI":"10.1186\/s12929-019-0531-z"},{"key":"7058_CR35","doi-asserted-by":"crossref","unstructured":"Chan CM, Huang CH, Li HJ, et al. Protective effects of resveratrol against UVA-induced damage in ARPE19 cells. Int J Mol Sci. 2015;16(3):5789-5802. Published 2015 Mar 12. doi:10.3390\/ijms16035789","DOI":"10.3390\/ijms16035789"},{"key":"7058_CR36","doi-asserted-by":"crossref","unstructured":"Chan CM, Huang DY, Huang YP, et al. Methylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction. J Cell Mol Med. 2016;20(9):1749-1760. doi:10.1111\/jcmm.12893","DOI":"10.1111\/jcmm.12893"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07058-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:48:20Z","timestamp":1783403300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7058"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07058-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. This study does not include individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}},{"value":"Not applicable. This study does not involve human participants, human data, human tissue, or animals.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}